Retour aux projets

18269.2 PFLS-LS

A novel, localized approach to immune checkpoint modulation for the therapy of cancer

Résumé

A novel, localized approach to immune checkpoint modulation for the therapy of cancer

Textes supplémentaires

Abstract

The pathophysiology of chronic inflammation and epithelial cancer are casuatively linked. Interleukin (IL)-23 and IL-23 receptor (IL23R) expressing cells are heavily implicated in the development of various malignancies. In this project the potential of a bispecific antibody fragment specifically depleting IL23R expressing cells shall be evaluated to reactivate the host anti-cancer immune response.

Participants

David Urech

Wirtschaftspartner

d.urech@numab.com

Numab AG David Urech Einsiedlerstrasse 34 8820 Wädenswil ZH CH

Burkhard Becher

Kontaktperson

becher@immunology.uzh.ch

Universität Zürich Burkhard Becher Winterthurerstrasse 190 8057 Zürich ZH CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2016-04-30
Date de fin
2019-04-30
Coûts totaux approuvés
CHF 433563.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T490 Biotechnology 100.0%